Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE vs LAMIVUDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMTRICITABINE vs LAMIVUDINE: Safety Overview

Metric EMTRICITABINE LAMIVUDINE
Total FAERS Reports 3,718 16,685
Deaths Reported 499 1,838
Death Rate 13.4% 11.0%
Hospitalizations 797 3,442
Average Patient Age 42.2 yrs 43.0 yrs
% Female Patients 41.9% 35.2%
FDA Approval Date Jul 2, 2003 Apr 19, 2018
Manufacturer Gilead Sciences, Inc Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Prescription